Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick

    Editors Pick - Page 67

    IHH offers Rs 160 per share for Fortis healthcare

    IHH offers Rs 160 per share for Fortis healthcare

    Ruby Khatun Khatun14 April 2018 10:30 AM IST
    New Delhi: Malaysia's IHH Healthcare has joined the race to acquire India's troubled Fortis Healthcare, offering to acquire shares at up to Rs 160...
    Founders of Dabur, Hero jointly bid Rs 1,250 crore for Fortis

    Founders of Dabur, Hero jointly bid Rs 1,250 crore for Fortis

    Ruby Khatun Khatun13 April 2018 1:29 PM IST
    New Delhi: Fortis Healthcare said it has received an "unsolicited binding offer" from Hero Enterprise Investment Office and Burman Family Office to...
    IHH proposes 1.3 billion dollar bid for Fortis: Report

    IHH proposes 1.3 billion dollar bid for Fortis: Report

    Ruby Khatun Khatun12 April 2018 3:37 PM IST
    IHH Healthcare Berhad has proposed a potential bid of as much as $1.3 billion for Fortis Healthcare Ltd. that tops an offer from a TPG-backed...
    Bring Cataract Lenses, Syringes, IV Fluid Sets, Urine Bags under Price Ceiling: Maha Govt tells Health Ministry

    Bring Cataract Lenses, Syringes, IV Fluid Sets, Urine Bags under Price Ceiling: Maha Govt tells Health Ministry

    Ruby Khatun Khatun11 April 2018 4:10 PM IST
    Mumbai: The Maharashtra government has submitted a report to the Union Health Ministry, seeking the addition of 18 medical tools or equipments in the...
    Manipal Health raises offer for Fortis Healthcare- Firm now valued at Rs 6,061 crore

    Manipal Health raises offer for Fortis Healthcare- Firm now valued at Rs 6,061 crore

    Ruby Khatun Khatun11 April 2018 9:44 AM IST
    New Delhi: Manipal Health Enterprises raised its offer for Fortis Healthcare Ltd by valuing the hospital business higher at Rs 6,061 crore, according...
    Max India in talks to buyout partner in Max Healthcare

    Max India in talks to buyout partner in Max Healthcare

    Ruby Khatun Khatun10 April 2018 4:04 PM IST
    New Delhi: Max India on Monday said its board will consider buying out its equal partner in the healthcare business, Life Healthcare Group Holdings,...
    Rakesh Kumar Vats given additional charge of NPPA Chairman

    Rakesh Kumar Vats given additional charge of NPPA Chairman

    Ruby Khatun Khatun9 April 2018 12:15 PM IST
    New Delhi: Rakesh Kumar Vats, Additional Secretary, Ministry of Health and Family Welfare has been given the additional charge of chairman of drug...
    Novartis to buy AveXis for 8.7 billion dollars gene therapy deal

    Novartis to buy AveXis for 8.7 billion dollars gene therapy deal

    Ruby Khatun Khatun9 April 2018 10:00 AM IST
    Novartis is moving further into gene therapy with an $8.7 billion deal for AveXis that gives the Swiss drugmaker a rare-disease treatment seen reaping...
    Create separate drug controller for AYUSH medicines: Parliamentary Committee

    Create separate drug controller for AYUSH medicines: Parliamentary Committee

    Ruby Khatun Khatun8 April 2018 10:30 AM IST
    New Delhi: A parliamentary committee sought the creation of a separate drug controller for AYUSH medicines and drugs in a time-bound manner to ensure...
    Health ministry bans sale of 14 steroid creams sans doctor’s prescription

    Health ministry bans sale of 14 steroid creams sans doctor’s prescription

    Ruby Khatun Khatun7 April 2018 2:10 PM IST
    New Delhi: Through a recent gazette notification, Ministry of Health And Family Welfare has banned the over-the-counter (OTC) sale of 14 steroid-based...
    Natco launches generic version of multiple sclerosis drug in India

    Natco launches generic version of multiple sclerosis drug in India

    Ruby Khatun Khatun7 April 2018 10:00 AM IST
    New Delhi: Drug firm Natco Pharma said it has launched a generic version of Teriflunomide tablets used for the treatment of relapsing and remitting...
    Chemists in Ahmedabad to call shutter down before 11pm

    Chemists in Ahmedabad to call shutter down before 11pm

    Ruby Khatun Khatun6 April 2018 10:43 AM IST
    AHMEDABAD: Most of the chemists across Ahmedabad have taken a collective call to shut shop before 11 pm in order to make time for their families and...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Novartis Expiry of Patent for Blockbuster Vildagliptin to Clear Way for Competitors

    Novartis Expiry of Patent for Blockbuster Vildagliptin to Clear Way for Competitors

    French court dismisses damage claims against Merck over Levothyrox

    French court dismisses damage claims against Merck over Levothyrox

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok